Advertisement

Journal of Neurology

, 256:513 | Cite as

The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis

  • Aksel SivaEmail author
  • Sabahattin Saip
ENS TEACHING REVIEW

Abstract

Behçet’s Syndrome (BS) is a multi-system, vascular-inflammatory disease of unknown origin, involving the nervous system in a subgroup of patients. The growing clinical and imaging evidence suggests that primary neurological involvement in BS may be subclassified into two major forms: the first one, which is seen in the majority of patients, may be characterized as a vascular-inflammatory central nervous system (CNS) disease, with focal or multifocal parenchymal involvement mostly presenting with a subacute brainstem syndrome and hemiparesis; the other, which has few symptoms and a better neurological prognosis, may be caused by isolated cerebral venous sinus thrombosis and intracranial hypertension. These two types rarely occur in the same individual, and their pathogenesis is likely to be different. Isolated behavioral syndromes and peripheral nervous system involvement are rare, whereas a nonstructural vascular type headache is relatively common and independent from neurological involvement. Neurologic complications secondary to systemic involvement of BS such as cerebral emboli from cardiac complications of BS and increased intracranial pressure due to superior vena cava syndrome, as well as neurologic complications related to BS treatments such as CNS neurotoxicity with cyclosporine and peripheral neuropathy with the use of thalidomide or colchisin are considered as secondary neurological complications of this syndrome. As the neurological involvement in this syndrome is so heterogeneous, it is difficult to predict its course and prognosis, and response to treatment. Currently, treatment options are limited to attack and symptomatic therapies with no evidence for the efficacy of any long term preventive treatment.

Key words

Behçet’s disease neurologic involvement differential diagnosis therapy 

References

  1. 1.
    Akbulut L, Gur G, Bodur H, Alli N, Borman P (2007) Peripheral neuropathy in Behçet disease: an electroneurophysiological study. Clin Rheumatol 26:1240–1244CrossRefPubMedGoogle Scholar
  2. 2.
    Akman-Demir G, Bahar S, Baykan-Kurt B, Gürvit IH, Serdaroğlu P (1996) Intracranial hypertension in Behçet’s Disease. Eur J Neurol 3:66–70Google Scholar
  3. 3.
    Akman-Demir G, Serdaroğlu P, Tasçi B and the Neuro-Behçet Study Group (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. Brain 122:2171–2181CrossRefPubMedGoogle Scholar
  4. 4.
    Aktaş EG, Kaplan M, Ozveren MF (2008) Basilar artery aneurysm associated with Behçet’s Disease: a case report. Turk Neurosurg 18:35–38PubMedGoogle Scholar
  5. 5.
    Al-Araji A, Sharquie K, Al-Rawi Z (2003) Prevalence and patterns of neurological involvement in Behçet’s disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 74:608–613CrossRefPubMedGoogle Scholar
  6. 6.
    Atabay C, Erdem E, Kansu T, Eldem B (1992) Eales — disease with internuclear ophthalmoplegia. Ann Ophthalmol 24:267–270PubMedGoogle Scholar
  7. 7.
    Atasoy HT, Tunc TO, Unal AE, Emre U, et al. (2007) Peripheral nervous system involvement in patients with Behçet disease. The Neurologist 13:225–230CrossRefPubMedGoogle Scholar
  8. 8.
    Aykutlu E, Baykan B, Serdaroğlu P, et al. (2002) Epileptic seizures in Behçet disease. Epilepsia 43:832–835CrossRefPubMedGoogle Scholar
  9. 9.
    Aykutlu E, Baykan B, Akman-Demir G, Topcular B, Ertas M (2006) Headache in Behçet’s disease. Cephalalgia 26:180–186CrossRefPubMedGoogle Scholar
  10. 10.
    Bahar S, Çoban O, Gürvit H, Akman-Demir F, Gökyiğit A (1993) Spontaneus dissection of the extracranial vertebral artery with spinal subarachnoid hemorrhage in a patient with Behçet’s disease. Neuroradiology 35:352–354CrossRefPubMedGoogle Scholar
  11. 11.
    Behçet H (1937) Uber residivierende, aphtöse, durch ein virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Derm Woschenscr 105:1152–1157Google Scholar
  12. 12.
    Bogdanova D, Milanov I, Georgiev D (1998) Parkinsonian syndrome as a neurological manifestation of Behçet’s disease. Can J Neurol Sci 25:82–85PubMedGoogle Scholar
  13. 13.
    Bussone G, La Mantia L, Boiardi A, Giovannini P (1982) Chorea in Behçet’s Syndrome. J Neurol 227:89–92CrossRefPubMedGoogle Scholar
  14. 14.
    Cetinel B, Obek C, Solok V, Yaycioglu O, Yazici H (1998) Urologic screening for men with Behçet’s syndrome. Urology 52:863–865CrossRefPubMedGoogle Scholar
  15. 15.
    Fujikawa K, Aratake K, Kawakami A, Aramaki T, et al. (2007) Successful treatment of refractory neuro-Behçet’s disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Ann Rheum Dis 66:136–137CrossRefPubMedGoogle Scholar
  16. 16.
    Gardner RC, Schmahmann JD (2008) Ataxia and cerebellar atrophy — a novel manifestation of neuro-Behçet disease? Mov Disord 23(2):308–309CrossRefGoogle Scholar
  17. 17.
    Goodwin J (2008) The Vogt-Koyanagi-Harada syndrome. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com. Accessed 1 August 2008Google Scholar
  18. 18.
    Green AL, Mitchell PJ (2000) Spinal cord Neurobehçet’s disease detected on magnetic resonance imaging. Australasian Radiology 44:201–203CrossRefPubMedGoogle Scholar
  19. 19.
    Hadfield MG, Aydın F, Lippman HR, Sanders KM (1997) Neuro-Behçet’s disease. Clin Neuropathol 16:55–60PubMedGoogle Scholar
  20. 20.
    Haghighi AB, Rahman P, Ali-Reza N (2007) The pathological presentations of neuro-Behçet disease: A case report and review of the literature. The Neurologist 13:209–214CrossRefPubMedGoogle Scholar
  21. 21.
    Haghighi AB, Aflaki E, Ketabchi L (2008) The prevalence and characteristics of different types of headache in patients with Behçet’s disease, a case-control study. Headache 48:424–429CrossRefGoogle Scholar
  22. 22.
    Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gül A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H (2008) EULAR recommendations for the management of Behçet’s disease: report of a task force of the European Standing Committee for International Clinical Sstudies Including Therapeutics (ESCISIT). Ann Rheum Dis 67(12):1656–1662CrossRefPubMedGoogle Scholar
  23. 23.
    Hatzitolios A, Savopoulos C, Ntaios G, Tsirogianni E, Baltatzi M, Apostolopoulou M, Dimitrakoudi E (2008) Recurrent peripheral facial paresis may constitute the sole clinical manifestation in neuro-Behçet disease. Neurologist 14:77CrossRefPubMedGoogle Scholar
  24. 24.
    Hirohata S, Suda H, Hashimoto T (1998) Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet’s disease. J Neurol Sci 14(159):181–185CrossRefGoogle Scholar
  25. 25.
    Hirose M, Ikeuchi T, Hayashi S, et al. (2006) A possible variant of neuro-Behçet disease presenting with chronic progressive ataxia without mucocutaneo-ocular symptoms. Rheumatol Int 27:61–66CrossRefPubMedGoogle Scholar
  26. 26.
    Hisanaga K, Iwasaki Y, Itoyama Y (2005). Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology 64:1756–1761CrossRefPubMedGoogle Scholar
  27. 27.
    Hisanaga K (2007) Neuro-neutrophilic disease: neuro-Behçet disease and neuro-Sweet disease. Intern Med 46:153–154CrossRefPubMedGoogle Scholar
  28. 28.
    Hiwatashi A, Garber T, Moritani T, et al. (2003) Diffusion-weighted MR imaging of neuro-Behçet’s disease: a case report. Neuroradiology 45:468–471CrossRefPubMedGoogle Scholar
  29. 29.
    Houman MH, Hamzaoui-B’Chir S, Ben Ghorbel I, et al. (2002) Neurologic manifestations of Behçet’s disease: analysis of a series of 27 patients. Rev Med Interne 23:592–606CrossRefPubMedGoogle Scholar
  30. 30.
    Huang WS, Chiu PY, Kao A, et al. (2002) Decreased cerebral blood flow in neuro-Behçet’s syndrome patients with neuropsychiatric manifestations and normal magnetic resonance imaging — a preliminary report. J Neuroimaging 12:355–359CrossRefPubMedGoogle Scholar
  31. 31.
    International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080Google Scholar
  32. 32.
    International Study Group for Behçet’s disease (1992) Evaluation of diagnostic (classification) criteria in Behçet’s disease- towards internationally agreed criteria. Br J Rheumatol 31:299–308Google Scholar
  33. 33.
    Kang DW, Chu K, Cho JY, et al. (2001) Diffusion-weighted magnetic resonance imaging in neuro-Behçet’s disease. J Neurol Neurosurg Psychiatry 70:412–413CrossRefPubMedGoogle Scholar
  34. 34.
    Kansu E (1996) Endothelial cell dysfunction in Behçet’s disease. In: Ansell BM, Bacon PA, Lie JT, Yazıcı H (eds) Vasculitides. London, Chapman&Hall, pp 207–221Google Scholar
  35. 35.
    Kansu T, Kirkali P, Kansu E, Zileli T (1989) Optic neuropathy in Behçet’s disease. J Clin Neuro Opthalmol 9:2772–2780Google Scholar
  36. 36.
    Kantarci O, Siva A (2006) Behçet’s disease: diagnosis and management (Chapter 96). In: Noseworthy J (ed) Neurological Therapeutics: Principles and Practice. Second edition. Informa Healthcare, pp 1196–1206Google Scholar
  37. 37.
    Karandreas N, Tsivgoulis G, Zambelis T, Kokotis P, Rapidi A, Petropoulou K, Spengos K (2007) Urinary frequency in a case of Neuro-Behçet disease involving the brainstem — clinical, electrophysiological and urodynamic features. Clin Neurol Neurosurg 109:806–810CrossRefPubMedGoogle Scholar
  38. 38.
    Karatas GK, Onder M, Meray J (2002) Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 22:155–159CrossRefPubMedGoogle Scholar
  39. 39.
    Kececi H, Akyol M (2001) P300 in Behçet’s patients without neurological manifestations. Can J Neurol Sci 28:66–69PubMedGoogle Scholar
  40. 40.
    Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122:2171–2181CrossRefGoogle Scholar
  41. 41.
    Kidd D (2006) The prevalence of headache in Behçet’s syndrome. Rheumatology 45:621–623CrossRefPubMedGoogle Scholar
  42. 42.
    Kikuchi S, Niino M, Shinpo K, et al. (2002) Intracranial hemorrhage in neuro-Behçet’s syndrome. Intern Med 41:692–695CrossRefPubMedGoogle Scholar
  43. 43.
    Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive Neuro-Behçet’s syndrome. J Neurol Sci 272:99–105CrossRefPubMedGoogle Scholar
  44. 44.
    Kizilkilic O, Albayram S, Adaletli I, et al. (2003) Endovascular treatment of Behçet’s disease-associated intracranial aneurysms: report of two cases and review of the literature. Neuroradiology 45:328–334PubMedGoogle Scholar
  45. 45.
    Koç Y, Güllü I, Akpek G, et al. (1992) Vascular involvement in Behçet’s disease. J Rheumatology 19:402–410Google Scholar
  46. 46.
    Koçer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in Neuro-Behçet’s syndrome: an MR study. AJNR 20:1015–1024PubMedGoogle Scholar
  47. 47.
    Kotake S, Higashi K, Yoshikawa K, Sasamato Y, Okamoto T, Matsuda H (1999) Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology 106:586–589CrossRefPubMedGoogle Scholar
  48. 48.
    Kotter I, Gunaydin I, Batra M, Vonthein R, Stubiger N, Fierlbeck G, Melms A (2006) CNS involvement occurs more frequently in patients with Behçet’s disease under cyclosporin A than under other medications results of a retrospective analysis of 117 cases. Clin Rheumatol 25:482–486CrossRefPubMedGoogle Scholar
  49. 49.
    Krausea I, Weinberger A (2008) Behçet’s disease. Curr Opin Rheumatol 20:82–87CrossRefGoogle Scholar
  50. 50.
    Krespi Y, Akman-Demir G, Poyraz M, Tugcu B, Coban O, Tuncay R, Serdaroğlu P, Bahar S (2001) Cerebral vasculitis and ischaemic stroke in Behçet’s disease: report of one case and review of the literature. Eur J Neurol 8:719–722CrossRefPubMedGoogle Scholar
  51. 51.
    Kural-Seyahi E, Fresko I, Seyahi N, et al. (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60CrossRefPubMedGoogle Scholar
  52. 52.
    Kurtzke JF (1983) Rating neurological impairment in MS: An expended disability status scale (EDSS). Neurology 33:1444–1452PubMedGoogle Scholar
  53. 53.
    Lakhanpal S, O’Duffy JD, Lie JT (1998) Pathology. In: Plotkin GR, Calabro JJ, O’Duffy JD (eds) Behçet’s disease. A contemporary synopsis. Futura, New York, pp 101–142Google Scholar
  54. 54.
    Licata G, Pinto A, Tuttolomondo A, Banco A, Ciccia F, Ferrante A, Triolo G (2003) Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet’s syndrome. Ann Rheum Dis 62:280–281CrossRefPubMedGoogle Scholar
  55. 55.
    Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D (2002) Neurological manifestations of Behçet’s disease in a Caribbean population: clinical and imaging findings. J Neurol 249:410–418CrossRefPubMedGoogle Scholar
  56. 56.
    Matsuo K, Yamada K, Nakajima K, Masanori Nakagawa (2005) Neuro-Behçet disease mimicking brain tumor. AJNR Am J Neuroradiol 26:650–653PubMedGoogle Scholar
  57. 57.
    Miller DH, Ormerod IEC, Gibson A, DuBoulay EPGH, Rudge P, McDonald WI (1987) MRI brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 29:226–23lCrossRefPubMedGoogle Scholar
  58. 58.
    Mitsui Y, Mitsui M, Urakami R, Kihara M, Takasahi M, Kusunoki S (2005) Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to icroemulsion formulation. Int Med 44:149–152CrossRefGoogle Scholar
  59. 59.
    Monastero R, Mannino M, Lopez G, et al. (2003) Prevalence of headache in patients with Behçet’s disease without overt neurological involvement. Cephalalgia 23:105–108CrossRefPubMedGoogle Scholar
  60. 60.
    Morrissey SP, Miller DH, Harmszewski R, et al. (1993) Magnetic resonance imaging of the central nervous system in Behçet’s disease. Eur Neurol 33:287–293CrossRefPubMedGoogle Scholar
  61. 61.
    Namer IJ, Karabudak R, Zileli T, et al. (1987) Peripheral nervous system involvement in Behçet’s Disease. Eur Neurol 26:235–240CrossRefPubMedGoogle Scholar
  62. 62.
    Nobili F, Cutolo M, Sulli A, et al. (2002) Brain functional involvement by perfusion SPECT in systemic sclerosis and Behçet’s disease. Ann N Y Acad Sci 966:409–414CrossRefPubMedGoogle Scholar
  63. 63.
    O’Duffy JD, Robertson DM, Goldstein NP (1984) Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet’s disease. Am J Med 76:75–84CrossRefPubMedGoogle Scholar
  64. 64.
    O’Duffy JD (1990) Vasculitis in Behçet’s disease. Rheum Dis Clin North Am 16:423–431PubMedGoogle Scholar
  65. 65.
    Oktem-Tanor O, Baykan-Kurt B, Gurvit IH, Akman-Demir G, Serdaroğlu P (1999) Neuropsychological follow-up of 12 patients with neuro-Behçet disease. J Neurol 246:113–119CrossRefPubMedGoogle Scholar
  66. 66.
    Özdoğan H (1994) Behçet’s syndrome in children. Rheumatology in Europe 23(Suppl 12):34Google Scholar
  67. 67.
    Patel AV, Stickler DE, Tyor WR (2007) Neurosarcoidosis. Curr Treat Options Neurol 9:161–168CrossRefPubMedGoogle Scholar
  68. 68.
    Pellechia MT, Cuomo T, Striano S, et al. (1999) Paroxysmal dystonia in Behçet’s disease. Mov Disord 14:177–179CrossRefGoogle Scholar
  69. 69.
    Perniciaro C, Molina J (1991) Cerebrovascular aneurysms in patients with Behçet’s disease. In: O’Duffy JD, Kökmen E (eds) Behçet’s disease: Basic and clinical aspects. New York: Marcel Dekker, pp 119–123Google Scholar
  70. 70.
    Park JH, Jung MK, Bang CO, Park MK, et al. (2002) Neuro-Behçet’s disease mimicking a cerebral tumor: a case report. J Korean Med Sci 17:718–722PubMedGoogle Scholar
  71. 71.
    Park DM (2008) Neurosarcoidosis. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com, accessed August 1, 2008Google Scholar
  72. 72.
    Ramachandran TR (2008) Cogan’s syndrome. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com, accessed August 1, 2008Google Scholar
  73. 73.
    Ribi C, Sztajzel R, Delavelle J, Chizzolini C J (2005) Efficacy of TNF a blockade in cyclophosphamide resistant neuro-Behçet disease. Neurol Neurosurg Psychiatry 76:1733–1735CrossRefGoogle Scholar
  74. 74.
    Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44:1977–1983CrossRefPubMedGoogle Scholar
  75. 75.
    Sağduyu A, Sirin H, Oksel F, et al. (2002) An unusual case of Behçet’s disease presenting with bilateral internal carotid artery occlusion. J Neurol Neurosurg Psychiatry 73(3):343CrossRefPubMedGoogle Scholar
  76. 76.
    Said G (2000) Sarcoidosis of the nervous system. Neurological manifestations in systemic diseases. ENS Teaching Course 12, Syllabus, pp 74–85Google Scholar
  77. 77.
    Saip S, Siva A, Altıntas A, et al. (2005) Headache in Behçet’s syndrome. Headache 45:911–919CrossRefPubMedGoogle Scholar
  78. 78.
    Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341:1284–1291CrossRefPubMedGoogle Scholar
  79. 79.
    Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62:442–451CrossRefPubMedGoogle Scholar
  80. 80.
    Sarui H, Maruyama T, Ito I, et al. (2002) Necrotising myositis in Behçet’s disease: characteristic features on magnetic resonance imaging and a review of the literature. Ann Rheum Dis 61:751–752CrossRefPubMedGoogle Scholar
  81. 81.
    Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of longstanding neuro-Behçet’s disease with infliximab in patients with refractory disease. J Rheumatol 32:181–118PubMedGoogle Scholar
  82. 82.
    Schmolck H (2005) Large thalamic mass due to neuro-Behçet disease. Neurology 65:436CrossRefPubMedGoogle Scholar
  83. 83.
    Serdaroğlu P, Yazici H, Özdemir C, et al. (1989) Neurological involvement in Behçet’s syndrome: a prospective study. Arch Neurol 46:265–269PubMedGoogle Scholar
  84. 84.
    Serdaroğlu P (1998) Behçet’s disease and the nervous system. J Neurol 245:197–205CrossRefPubMedGoogle Scholar
  85. 85.
    Serdaroğlu P (1989) Neuromuscular manifestations in the course of Behçet’s Disease. Acta Myologica 2:41–45Google Scholar
  86. 86.
    Siva A, Özdogan H, Yazici H, et al. (1986) Headache, neuro-psychiatric and computerized tomography findings in Behçet’s syndrome. In: Lehner T, Barnes CG (eds) Recent advances in Behçet’s disease. Royal Society of Medicine Service, London, pp 247–254Google Scholar
  87. 87.
    Siva A, Necdet V, Yurdakul S, et al. (1991) Neuroradiological findings in Neuro-Behçet Syndrome. In: O’Duffy JD, Kökmen E (eds) Behçet’s disease: Basic and clinical aspects. Marcel Dekker, New York, pp 323–329Google Scholar
  88. 88.
    Siva A, Altıntas¸ A (2000) Neuro-Behçet Syndrome. In Said G (ed) Intravenous Immunoglobulins in the Treatment of Neurological Disorders. Martin Dunitz Publishers, London, pp 115–126Google Scholar
  89. 89.
    Siva A, Fresko I (2000) Behçet’s Disease. Current Treatment Options in Neurology 2:435–447CrossRefPubMedGoogle Scholar
  90. 90.
    Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behçet’s disease: diagnostic & prognostic aspects of neurological involvement. J Neurol 248:95–103CrossRefPubMedGoogle Scholar
  91. 91.
    Siva A (2001) Vasculitis of the nervous system. J Neurol 248:451–468CrossRefPubMedGoogle Scholar
  92. 92.
    Siva A, Altıntas¸ A, Saip S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17:347–357CrossRefPubMedGoogle Scholar
  93. 93.
    Sener RN (2003) Neuro-Behçet’s disease: diffusion MR imaging and proton MR spectroscopy. Am J Neuroradiol 24:1612–1614PubMedGoogle Scholar
  94. 94.
    Sfikakis PP, Markomichelakis N, Alpsoy E, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H (2007) Anti-TNF therapy in the management of Behçet’s disease: review and basis for recommendations. Rheumatology 46:736–741CrossRefPubMedGoogle Scholar
  95. 95.
    St. Clair EW, McCallum RM (1999) Cogan’s syndrome. Curr Opin Rheumatol 11:47–52CrossRefPubMedGoogle Scholar
  96. 96.
    Stigsby B, Bohlega S, McLean DR, Al-Kawi MZ (2000) Transcranial magnetic stimulation in Behçet’s disease: a cross-sectional and longitudinal study with 44 patients comparing clinical, neuroradiological, somatosensory and brain-stem auditory evoked potential findings. Clin Neurophysiol 111:1320–1329CrossRefPubMedGoogle Scholar
  97. 97.
    Susac JO, Egan RA, Rennebohm RM, Lubow M (2007) Susac’s syndrome: 1975–2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci 257:270–272CrossRefPubMedGoogle Scholar
  98. 98.
    Takeuchi A, Kodama M, Takatsu M, et al. (1989) Mononeruritis multiplex in incomplete Behçet’s Disease: A case report and the review of the literature. Clin Rheumatol 8:375–380CrossRefPubMedGoogle Scholar
  99. 99.
    Tunc T, Ortapamuk H, Naldoken S, Ergun U, Ciliz D, Atasoy HT, Okuyucu E, Inan LE, Eksioglu M (2006) Subclinical neurological involvement in Behçet’s disease. Neurol India 54:408–411CrossRefPubMedGoogle Scholar
  100. 100.
    Tunc R, Saib S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet’s syndrome. Ann Rheum Dis 63:1693–1694CrossRefPubMedGoogle Scholar
  101. 101.
    Wechsler B, Vidailhet M, Bousser MG, et al. (1992) Cerebral venous sinus thrombosis in Behçet’s disease: Long term follow-up of 25 cases. Neurology 42:614–618PubMedGoogle Scholar
  102. 102.
    Yazıcı H, Yurdakul S, Hamuryudan V (2001) Behçet disease [Vasculitis syndromes]. Curr Opin Rheumatol 13:18–22CrossRefPubMedGoogle Scholar
  103. 103.
    Yazıcı H (2003) Behçet syndrome: an update. Curr Rheumatol Rep 5:195–219CrossRefPubMedGoogle Scholar
  104. 104.
    Yazıcı H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nature Clinical Practice Rheumatology 3:151–155Google Scholar
  105. 105.
    Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroğlu P, Akman-Demir G (2007) Clinical characteristics and course of spinal cord involvement in Behçet’s disease. Eur J Neurol 14:729–737CrossRefPubMedGoogle Scholar
  106. 106.
    Yesilot N, Shehu M, Oktem-Tanor O, et al. (2006) Silent neurological involvement in Behçet’s disease. Clin Exp Rheumatol 24:S65–S70PubMedGoogle Scholar
  107. 107.
    Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. (1997) Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J 38:411–422PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2009

Authors and Affiliations

  1. 1.Hacı Emin Sok.No:20/7 NisantasiIstanbulTurkey
  2. 2.Clinical Neuroimmunology Unit, Dept. of NeurologyCerrahpaşa School of Medicine, University of IstanbulIstanbulTurkey

Personalised recommendations